Sign In
Buy ADXN
$5.95
+0.550 (+10.19%)
At Close: Aug 10, 2026
Addex Therapeutics Earnings Calls
Jun 30, 2026
(Upcoming)
| Release date | Aug 24, 2026 |
| EPS estimate | - |
| EPS actual | - |
| Revenue estimate | - |
| Revenue actual | - |
| Expected change | +/- 12.73% |
Mar 31, 2026
| Release date | Jun 15, 2026 |
| EPS estimate | - |
| EPS actual | - |
| Revenue estimate | - |
| Revenue actual | - |
Dec 31, 2025
-$1.94 (-36.00%)
| Release date | Apr 30, 2026 |
| EPS estimate | -$1.42 |
| EPS actual | -$1.94 |
| EPS Surprise | -36.00% |
| Revenue estimate | 236.616K |
| Revenue actual | 313K |
| Revenue Surprise | 32.28% |
Sep 30, 2025
| Release date | Dec 04, 2025 |
| EPS estimate | - |
| EPS actual | -$1.50 |
| Revenue estimate | 236.616K |
| Revenue actual | 37.364K |
| Revenue Surprise | -84.21% |
Last 4 Quarters for Addex Therapeutics
Below you can see how ADXN performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
Sep 30, 2025
| Release date | Dec 04, 2025 |
| Price on release | $8.38 |
| EPS estimate | - |
| EPS actual | -$1.50 |
| Date | Price |
|---|---|
| Nov 28, 2025 | $7.66 |
| Dec 01, 2025 | $8.20 |
| Dec 02, 2025 | $8.05 |
| Dec 03, 2025 | $8.99 |
| Dec 04, 2025 | $8.38 |
| Dec 05, 2025 | $7.77 |
| Dec 08, 2025 | $8.05 |
| Dec 09, 2025 | $7.49 |
| Dec 10, 2025 | $7.41 |
| 4 days before | 9.34% |
| 4 days after | -11.58% |
| On release day | -7.28% |
| Change in period | -3.32% |
Dec 31, 2025
Missed
| Release date | Apr 30, 2026 |
| Price on release | $6.96 |
| EPS estimate | -$1.42 |
| EPS actual | -$1.94 |
| EPS surprise | -36.00% |
| Date | Price |
|---|---|
| Apr 24, 2026 | $7.00 |
| Apr 27, 2026 | $6.59 |
| Apr 28, 2026 | $6.74 |
| Apr 29, 2026 | $7.00 |
| Apr 30, 2026 | $6.96 |
| May 01, 2026 | $7.00 |
| May 04, 2026 | $6.93 |
| May 05, 2026 | $6.90 |
| May 06, 2026 | $6.85 |
| 4 days before | -0.571% |
| 4 days after | -1.58% |
| On release day | 0.575% |
| Change in period | -2.14% |
Mar 31, 2026
| Release date | Jun 15, 2026 |
| Price on release | $6.00 |
| EPS estimate | - |
| EPS actual | - |
| Date | Price |
|---|---|
| Jun 09, 2026 | $6.23 |
| Jun 10, 2026 | $6.50 |
| Jun 11, 2026 | $6.20 |
| Jun 12, 2026 | $6.45 |
| Jun 15, 2026 | $6.00 |
| Jun 16, 2026 | $6.21 |
| Jun 17, 2026 | $6.21 |
| Jun 18, 2026 | $6.20 |
| Jun 22, 2026 | $6.52 |
| 4 days before | -3.69% |
| 4 days after | 8.67% |
| On release day | 3.50% |
| Change in period | 4.65% |
Jun 30, 2026
(Upcoming)
| Release date | Aug 24, 2026 |
| Price on release | - |
| EPS estimate | - |
| EPS actual | - |
| Date | Price |
|---|---|
| Aug 04, 2026 | $5.69 |
| Aug 05, 2026 | $5.69 |
| Aug 06, 2026 | $5.80 |
| Aug 07, 2026 | $5.40 |
| Aug 10, 2026 | $5.95 |
Addex Therapeutics Earnings History
Earnings Calendar
FAQ
When is the earnings report for ADXN?
Addex Therapeutics Ltd (ADXN) has scheduled its earnings report for Aug 24, 2026 before the markets open.
What is the ADXN price-to-earnings (P/E) ratio?
ADXN P/E ratio as of Aug 10, 2026 (TTM) is -0.750.
What is the ADXN EPS forecast?
The forecasted EPS (Earnings Per Share) for Addex Therapeutics Ltd (ADXN) for the first fiscal quarter 2026 is $.
What are Addex Therapeutics Ltd's retained earnings?
On its balance sheet, Addex Therapeutics Ltd reported retained earnings of $0 for the latest quarter ending Mar 31, 2026.
What Is an Earnings Report?
An earnings report is usually issued quarterly (Q1, Q2, Q3 & Q4) by public companies to report their performance. Earnings reports typically include net income, earnings per share, earnings from continuing operations, and net sales. Looking at the earnings report investors can start gauge the financial health of the company and make even better decisions whether to buy, sell, or stay in the company. Fundamental analysts and value investors will typically hunt for stocks that continue to show good financial ratios and use a decline as an exit point. One of the most anticipated numbers for analysis is earnings per share because it indicates how much the company earned for its shareholders. The report will also indicate a possible dividend.
Earnings Report Content
Earnings reports generally provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. These figures are typically measured against previous quarters/years. Furthermore, the earnings report usually includes a summary and analysis from the CEO or company spokesman, alongside a more general view of the financials and future forecast.
What To Know About Earnings Reports?
Announcement of earnings for a stock, particularly for well followed large-capitalization stocks, can move the market. Stock prices can fluctuate wildly on days when the quarterly earnings report is released. Despite good reports, stocks may very well fall if the investors were expecting more or they believe the next quarter will not be as good. Investors always try to be ahead of the market and future earnings/losses are often discounted into the current price of the stock. It is natural for stocks to start to move in either direction a few days before the release of an earnings report.
